Syros Pharmaceuticals (NASDAQ:SYRS) Share Price Crosses Above 50 Day Moving Average – Here’s What Happened

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS)’s share price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0002. Syros Pharmaceuticals shares last traded at $0.0002, with a volume of 1,893 shares changing hands.

Syros Pharmaceuticals Trading Down 50.0%

The company has a market capitalization of $5,366.40, a P/E ratio of 0.00 and a beta of 1.31.

Syros Pharmaceuticals Company Profile

Syros Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, that is pioneering a new class of targeted therapeutics by focusing on the control of gene expression. Founded in 2015 as a spin-out from the Broad Institute, Syros leverages its proprietary gene control platform to identify and drug key noncoding regions of the genome that regulate disease-driving genes. The company’s approach aims to convert previously undruggable gene targets into precise medicines for patients with cancer and rare genetic disorders.

Syros’ lead development candidate, tamibarotene (SY-1425), is an oral, selective RARα agonist being evaluated in acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS) characterized by RARA dependence.